- Home
- XCUR vs REFR Comparison
XCUR vs REFR Comparison
Compare XCUR & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCUR
- REFR
- Stock Information
- Founded
- XCUR 2011
- REFR 1965
- Country
- XCUR United States
- REFR United States
- Employees
- XCUR N/A
- REFR N/A
- Industry
- XCUR Biotechnology: Pharmaceutical Preparations
- REFR Multi-Sector Companies
- Sector
- XCUR Health Care
- REFR Miscellaneous
- Exchange
- XCUR Nasdaq
- REFR Nasdaq
- Market Cap
- XCUR 43.6M
- REFR 48.3M
- IPO Year
- XCUR N/A
- REFR N/A
- Fundamental
- Price
- XCUR $13.22
- REFR $1.34
- Analyst Decision
- XCUR
- REFR
- Analyst Count
- XCUR 0
- REFR 0
- Target Price
- XCUR N/A
- REFR N/A
- AVG Volume (30 Days)
- XCUR 47.7K
- REFR 20.7K
- Earning Date
- XCUR 11-14-2024
- REFR 03-06-2025
- Dividend Yield
- XCUR N/A
- REFR N/A
- EPS Growth
- XCUR N/A
- REFR N/A
- EPS
- XCUR N/A
- REFR N/A
- Revenue
- XCUR $500,000.00
- REFR $1,335,531.00
- Revenue This Year
- XCUR N/A
- REFR N/A
- Revenue Next Year
- XCUR N/A
- REFR N/A
- P/E Ratio
- XCUR N/A
- REFR N/A
- Revenue Growth
- XCUR N/A
- REFR 46.83
- 52 Week Low
- XCUR $1.44
- REFR $1.16
- 52 Week High
- XCUR $36.00
- REFR $2.41
- Technical
- Relative Strength Index (RSI)
- XCUR 59.25
- REFR 45.78
- Support Level
- XCUR $10.10
- REFR $1.24
- Resistance Level
- XCUR $14.44
- REFR $1.45
- Average True Range (ATR)
- XCUR 1.86
- REFR 0.06
- MACD
- XCUR 0.38
- REFR 0.01
- Stochastic Oscillator
- XCUR 72.77
- REFR 47.62
About XCUR Exicure Inc.
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.
About REFR Research Frontiers Incorporated
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. Its revenue source comes from the licensing of technology.